Corrigendum for “Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib” [Acta Biomaterialia, 2023, 159, 237-246]
- Resource Type
- Erratum
- Source
- In
Acta Biomaterialia 15 September 2023 168:672-673 - Subject
- Language
- ISSN
- 1742-7061